Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations
Schnelles Gehen gleicht das Risiko für venöse Thromboembolien aus, das durch etablierte monogene Mutationen entsteht
Thrombosis and Haemostasis · 01.08.2025 · 125 (08) · 791-801
DOI: 10.1055/a-2461-3349 ↗Auf einen Blick
In der UK Biobank war ein flotter Gehstil mit geringerer VTE-Inzidenz verbunden als langsames Gehen. Der Zusammenhang zeigte sich auch in der Mendel-Randomisierung als kausal.
Fragestellung
Besteht ein Zusammenhang zwischen Gehgeschwindigkeit und venösen Thromboembolien, und ist der Effekt kausal sowie mit F2-/F5-Mutationen vergleichbar?
Methode
Kohortenstudie in der UK Biobank mit 445.261 Personen; Cox-Modelle, bidirektionale Mendel-Randomisierung und Mediation mit GWAS-Daten.
Ergebnisse
Nach 12,8 Jahren traten 11.155 VTE-Fälle auf. 10-Jahres-Inzidenz: 1,32 % bei flottem vs. 3,90 % bei langsamem Gehen; bei F2-Nichtträgern 1,70 %, bei F2-Trägern 2,94 %, bei F5-Trägern 3,62 %.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass ein flotter Gehstil das VTE-Risiko auf Populationsebene senkt und den durch Mendel-Mutationen bedingten Risikoanstieg teilweise ausgleicht.
Kernaussagen
- Flottes Gehen war mit niedrigerer 10-Jahres-VTE-Inzidenz verbunden
- Mendel-Randomisierung sprach für einen kausalen Effekt
- ALB und CYS vermittelten den Effekt teilweise
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2025. Verfasst von Wenyan Xian und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China. Hauptthemen laut MEDLINE: Venous Thromboembolism, Mutation, Prothrombin, Factor V. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Mendelian mutations in the Prothrombin gene (F2) and the factor V Leiden gene (F5) genes are established risk factors for venous thromboembolism (VTE). Walking pace is associated with the risk of coronary artery diseases, but no study has investigated its association with VTE. This study aimed to investigate the association and causality between walking pace and VTE, compare its population risk with established Mendelian mutations, and determine if blood biomarkers mediate its effect. We followed up 445,261 UK Biobank participants free of VTE at baseline. Self-reported walking pace was collected via touchscreen questionnaire at baseline. The carrier status of two Mendelian mutations in F2 and F5 genes was determined by the genotypes of rs1799963 (G20210A, c.*97 G > A) and rs6025 (p.R534Q), respectively. Cox proportional hazard model was used to estimate the effect of walking pace on incident VTE. We conducted a bidirectional Mendelian randomization (MR) analysis, by using 70 single-nucleotide polymorphisms (SNPs) from a walking pace genome-wide association studies (GWAS) and 93 SNPs from a VTE GWAS as instrumental variables. We used both individual-level data and GWAS summary statistics for mediation analysis. Over a median follow-up period of 12.8 years, 11,155 incident VTE cases were identified. The 10-year incidence rates for brisk and slow walking pace were 1.32% (confidence interval [CI]: 1.27–1.37%) and 3.90% (CI: 3.71–4.09%), respectively. For noncarriers, F2 and F5 carriers, the 10-year incidence rates were 1.70% (CI: 1.66–1.73%), 2.94% (CI: 2.66–3.22%), and 3.62% (CI: 3.39–3.84%), respectively. The overall risk of VTE for F5 mutation carriers with a brisk walking pace (2.65%) was smaller than that for noncarriers with a slow walking pace (3.66%). For F5 mutation carriers, brisk pace (but not steady pace) reduces the risk of VTE (p interaction < 0.05). MR analyses displayed a causal relationship (inverse variance weighted: p = 3.21 × 10−5) from walking pace to VTE incidence. Mediation analysis showed that serum albumin (ALB) and cystatin C (CYS) levels partially mediated the effect of brisk walking pace on the risk of VTE incidence, with mediation proportions of 8.7 to 11.7%, respectively. On the population scale, the protective effect of brisk walking pace offsets the risk of VTE caused by Mendelian mutations. We provided preliminary evidence that a brisk walking pace causally reduces the risk of VTE. Serum ALB and CYS partially mediate this effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
- School of Engineering, Johns Hopkins University, Baltimore, Maryland, United States.
- Shanghai Institute for Mathematics and Interdisciplinary Sciences, Fudan University, Shanghai, China.
- Department of Public and Ecosystem Health, Cornell University College of Veterinary Medicine, Ithaca, New York, United States.
- University of Exeter Medical School, Exeter, United Kingdom.
- School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Xian, W., Tao, Y., You, C., Sun, R., Ranson, J. M., Napolioni, V., Lau, P. W. C., & Huang, J. (2025). Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations. Thrombosis and Haemostasis, 125(08), 791-801. https://doi.org/10.1055/a-2461-3349
Vancouver
Xian W, Tao Y, You C, Sun R, Ranson JM, Napolioni V, et al. Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations. Thrombosis and Haemostasis. 2025;125(08):791-801. doi:10.1055/a-2461-3349
BibTeX
@article{Xian2025,
author = {Xian, Wenyan and Tao, Yifan and You, Chong and Sun, Ruinan and Ranson, Janice M and Napolioni, Valerio and Lau, Patrick W C and Huang, Jie},
title = {Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {08},
pages = {791--801},
doi = {10.1055/a-2461-3349}
}
EUVIMED